Can Abbott Laboratories(NYSE:ABT), Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA), and Ampio Pharmaceuticals Inc(NYSEMKT:AMPE) Advance In The Pharmaceutical Industry?

Posted by admin October 14, 2014 0 Comment 1505 views

New York, NY – GDP INSIDER  –  10/14/2014.

This article discusses three pharmaceutical companies: Abbott Laboratories(NYSE:ABT), Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA), and Ampio Pharmaceuticals Inc(NYSEMKT:AMPE)

Abbott Laboratories(NYSE:ABT) announced on Oct. 10th that the company had entered a new partnership with the World Marathon Majors, through which Abbott will become the first title sponsor of the race. The marathon series, which is comprised of the Tokyo, Boston, Virgin Money London, BMW Berlin, Bank of America Chicago, and TCS New York City Marathon, will be renamed the Abbott World Marathon Majors for the 2015 race season. Abbott hopes the partnership will help the company achieve its core mission of improving lives through the power of health.

Can Abbott Laboratories Improve Its Name Recognition? View Our Free ABT Analysis.

On Oct. 10th, Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) announced that the PRAC of the European Medicines Agency had recommended that Inclusig be used in Europe according to the previously approved indications. The product was, and will continue to be, approved for the treatment of adult patients with various forms of leukemia. Additionally, ARIAD announced that it had restructured its licensing agreement for ARIAD’s cell-signaling technology, which will result in ARIAD receiving an additional $50 million.

Should You Be Excited By Ariad’s Moves? Receive A Free ARIA Analysis.

Ampio Pharmaceuticals Inc(NYSEMKT:AMPE) currently has a bid price of $3.24 x 2,000 and an offer price of $4.15 x 100, figures which indicate the company’s value may be highly liquid. The company also traded for as little as the bid price yesterday, a new 52 week low for the company. The Colorado-based development stage biopharmaceutical company develops therapies for inflammatory conditions in the United States. The webcast of the company’s Sept. 20th shareholder meeting will be available until Oct. 20th, 2014.

What Does The Future Hold For Ampio Pharmaceuticals? Take A Look At Our Free AMPE Analysis.

About HotStockGains provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit for complete risks and disclosures.

Write Your Comment